menu
    • menu

    Looking for excipients offered by The Dow Chemical Company? Find information on The Dow Chemical Company's regulatory filings (DMFs), cGMP inspections, pricing availability, etc. on PharmaCompass.

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and ...
    Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and extending product life-cycles.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Dow Chemical CompanyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2030 Dow Center, Midland, MI 48674
    Telephone
    Telephone
    +1 800 447 4369
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharma.dupont.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dow-chemical
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    micAlchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets

    With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

    Impressions: 284

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

    Radio Compass
    06 May 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaConnecting People, Mentalities & MarketsConnecting People, Mentalities & Markets

    Connecting People, Mentalities & Markets
    Connecting People, Mentalities & Markets

    reelConnecting People, Mentalities & Markets

    This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

    Impressions: 402

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions

    The first quarter (Q1) of 2025 witnessed an impressive surge in Drug Master File (DMF) submissions to the US Food and Drug Administration (FDA), signaling a robust expansion in pharmaceutical development activities, the looming threat of tariffs notwithstanding.A total of 339 Type II DMFs were submitted during this period, as opposed to 235 submissions in Q1 2024, marking an exceptional increase of 44.26 percent. PharmaCompass’ data suggests that this is a record high for any first quarter.Overall, 440 DMFs were submitted across all categories (Types II, III, IV, and V) during Q1 2025, compared to 353 in the same period last year — representing a 24.65 percent increase.India and China continued to dominate the DMF landscape. India led with 162 submissions in Q1 2025, posting a remarkable 51.4 percent increase over 107 submissions recorded in Q1 2024. China followed with 135 submissions, representing a 33.66 percent increase over the 101 filings in Q1 2024.Taiwan sprung a surprise as a distant third. It made 12 DMF submissions in Q1 2025, as opposed to just one in Q1 2024. Western countries like the US, Spain, Germany, and Italy have maintained relatively stable or declining submission rates. Only the Netherlands showed significant growth with four DMF submissions in Q1 2025, up from zero in Q1 2024. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available)Indian giants MSN, Aurobindo, Cipla, Dr Reddy’s lead record-breaking DMF surgeIndia lived up to its “pharmacy of the world” reputation with the highest DMF submissions. In fact, seven of the top eight companies in the DMF tally were headquartered in India. MSN Group, emerged as the unequivocal leader with 23 submissions in Q1 2025, as against 15 in Q1 2024. Aurobindo Pharma increased its DMF activity from seven submissions in Q1 2024 to 12 in Q1 2025. Alivus Life Sciences, formerly known as Glenmark, made a dramatic leap with eight submissions in Q1 2025, quadrupling its previous year’s count of just two. Cipla more than doubled its DMF submissions — from three in Q1 2024 to eight in Q1 2025.Dr. Reddy’s Laboratories, one of India’s largest generic drugmakers, filed seven DMF submissions. The company’s Q1 2025 DMF portfolio includes high-value molecules like deucravacitinib, finerenone, enzalutamide, niraparib tosylate monohydrate, tucatinib, and tizanidine hydrochloride.Dr. Reddy’s has also indicated that they are open to manufacturing in the US. Meanwhile, Hetero Drugs filed seven submissions while Lee Pharma recorded six in Q1 2025.Chinese manufacturer Jiangsu East-Mab Biomedical Technology also established a significant presence with six DMFs. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Semaglutide, finerenone see most DMF submissions; first-time filings surge 64%Semaglutide and finerenone emerged as the most documented molecules in Q1 2025, each garnering nine DMF submissions. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized diabetes management and weight loss treatment, continues to attract significant manufacturer interest. Similarly, finerenone, a non-steroidal drug used in treating chronic kidney disease in type 2 diabetes patients, has garnered attention from manufacturers.Carfilzomib, used in multiple myeloma treatment, secured the third position with five DMF submissions. Deucravacitinib, a novel drug approved for moderate to severe plaque psoriasis, followed with four DMF submissions.There were several molecules with three DMF submissions each. Among them were tapinarof, a novel drug for psoriasis, and tirzepatide, a GLP-1/GIP receptor agonist that has shown remarkable efficacy in diabetes and weight management. During the quarter, 23 molecules received their inaugural DMF submissions. This number has risen by 64 percent since Q1 2024, when only 14 drugs saw their first DMF filings.In Q1 2025, these 23 first-time molecules collectively garnered 30 DMF submissions, with deucravacitinib emerging as the clear leader. Indian companies Dr. Reddy’s Laboratories and Cipla filed DMFs for this plaque psoriasis treatment as did Spain’s Curia and PMC Global.The Q1 2025 roster of first-time DMF filings include retatrutide (another GLP-1 receptor agonist), sotagliflozin, setmelanotide acetate, daridorexant, nusinersen, zavegepant, belzutifan, elacestrant dihydrochloride, selumetinib sulfate, sotorasib, atogepant, omadacycline tosylate, osilodrostat phosphate, ensifentrine, landiolol hydrochloride, maralixibat chloride, maribavir, methyl olivetolate, diazoxide choline, sparsentan, thinnertide, and vismodegib. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Our viewGiven Trump’s rhetoric around tariffs on imported drugs, the record-breaking DMF submissions in Q1 2025 sent out a strong message that the global pharmaceutical industry is willing to take on the complex geopolitical situation with resilience and strategic foresight.On a different note, the rise in DMF filings also indicate increased workload for the FDA staff, as also more inspections by the agency. It seems like more ‘laid off’ FDA employees will be asked to return to work in the coming days.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 570

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions

    #PharmaFlow by PHARMACOMPASS
    15 May 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    WHO warns of falsified cough syrup ingredients seized in Pakistan
    WHO warns of falsified cough syrup ingredients seized in Pakistan

    16 Apr 2024

    // REUTERS

    https://www.reuters.com/world/asia-pacific/who-warns-falsified-cough-syrup-ingredients-seized-pakistan-2024-04-15/

    REUTERS
    16 Apr 2024
    Share Share
    UK: EPO Oppositions Newsletter - Surge In Oppositions Matches Surge In Grants
    UK: EPO Oppositions Newsletter - Surge In Oppositions Matches Surge In Grants

    26 Mar 2020

    // David Lewin MONKAQ

    https://www.mondaq.com/uk/Intellectual-Property/719168/EPO-Oppositions-Newsletter--Surge-In-Oppositions-Matches-Surge-In-Grants

    David Lewin MONKAQ
    26 Mar 2020
    Share Share
    Takeda's Shire Takeover Seen Facing EU Scrutiny of Drug Research
    Takeda's Shire Takeover Seen Facing EU Scrutiny of Drug Research

    09 May 2018

    // Aoife White BLOOMBERG

    https://www.bloomberg.com/news/articles/2018-05-08/takeda-s-shire-takeover-seen-facing-eu-scrutiny-of-drug-research

    Aoife White BLOOMBERG
    09 May 2018
    Share Share
    Dow's Merck Does An About-Face, Releases Cancer Trial Results
    Dow's Merck Does An About-Face, Releases Cancer Trial Results

    16 Jan 2018

    // INVESTORS

    https://www.investors.com/news/technology/dows-merck-does-an-about-face-releases-cancer-trial-results/

    INVESTORS
    16 Jan 2018
    Share Share
    DowDuPont completes FMC acquisition, bolsters excipient biz
    DowDuPont completes FMC acquisition, bolsters excipient biz

    06 Nov 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2017/11/07/DowDuPont-completes-FMC-acquisition-bolsters-excipient-biz

    Dan Stanton IN PHARMATECHNOLOGIST
    06 Nov 2017
    Share Share
    Continuous Mfg : suitable excipients & more knowledge required, says Dow
    Continuous Mfg : suitable excipients & more knowledge required, says Dow

    25 Oct 2017

    // Flora Southey IN PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2017/10/25/Continuous-manufacturing-suitable-excipients-more-knowledge-required-says-Dow

    Flora Southey IN PHARMATECHNOLOGIST
    25 Oct 2017
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Excipients by Ingredients

    Upload your portfolio for free, ask us

    Excipients By applications

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact The Dow Chemical Company and get a quotation

    The Dow Chemical Company is a supplier offers 79 products (APIs, Excipients or Intermediates).

    Find a price of Simethicone bulk with DMF, JDMF offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk with JDMF offered by The Dow Chemical Company

    Find a price of Dimethicone bulk with JDMF offered by The Dow Chemical Company

    Find a price of Amberlite Irp69 bulk with DMF offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk with DMF offered by The Dow Chemical Company

    Find a price of Lauromacrogol bulk with JDMF offered by The Dow Chemical Company

    Find a price of Macrogol bulk with DMF offered by The Dow Chemical Company

    Find a price of Simethicone bulk with DMF offered by The Dow Chemical Company

    Find a price of XUS43598SF Ca bulk with JDMF offered by The Dow Chemical Company

    Find a price of XUS43598-SMA Na bulk with JDMF offered by The Dow Chemical Company

    Find a price of XUS43598-SMA Ca bulk with JDMF offered by The Dow Chemical Company

    Find a price of Amberlite Irp69 bulk offered by The Dow Chemical Company

    Find a price of Aspirin bulk offered by The Dow Chemical Company

    Find a price of Cholestyramine bulk offered by The Dow Chemical Company

    Find a price of Cyclopropane bulk offered by The Dow Chemical Company

    Find a price of Dead On Polystyrene bulk offered by The Dow Chemical Company

    Find a price of Decamethylcyclopentasiloxane bulk offered by The Dow Chemical Company

    Find a price of Dextropropoxyphene HCl bulk offered by The Dow Chemical Company

    Find a price of DPPC bulk offered by The Dow Chemical Company

    Find a price of Edetate Sodium bulk offered by The Dow Chemical Company

    Find a price of Erythromycin bulk offered by The Dow Chemical Company

    Find a price of Erythromycin Stearate bulk offered by The Dow Chemical Company

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by The Dow Chemical Company

    Find a price of Mesalazine bulk offered by The Dow Chemical Company

    Find a price of Oxygen bulk offered by The Dow Chemical Company

    Find a price of Sevelamer Hydrochloride bulk offered by The Dow Chemical Company

    Find a price of Tetracycline bulk offered by The Dow Chemical Company

    Find a price of Theophylline bulk offered by The Dow Chemical Company

    Find a price of Vinyl Chloride bulk offered by The Dow Chemical Company

    Find a price of Xenon Radioisotopes bulk offered by The Dow Chemical Company

    Find a price of Zoalene bulk offered by The Dow Chemical Company

    Find a price of TEFLURANE bulk offered by The Dow Chemical Company

    Find a price of SILICONE X-251 bulk offered by The Dow Chemical Company

    Find a price of X7-2837/Q7-2837 SILICONE EMULSION AND REINFORCING AGENT bulk offered by The Dow Chemical Company

    Find a price of DOW 132 (4-TERT-BUTYL-2-CHLOROPHENYLMETHYL METHY PHOSPHORAMIDATE) bulk offered by The Dow Chemical Company

    Find a price of POLYGLYCOL E-3350 NF bulk offered by The Dow Chemical Company

    Find a price of MANUF PROCESSES OF CAP-PLATE MENICON & MAFILCON SOFT CONTACT LENS MAT. bulk offered by The Dow Chemical Company

    Find a price of TERGITOL ANIONIC SURFACTANT 4 bulk offered by The Dow Chemical Company

    Find a price of PZ 5561.21 (DURAFILM PRODUCT) bulk offered by The Dow Chemical Company

    Find a price of CHIMERIC (MURINE VARIABLE, HUMAN CONSTANT) MONOCLONAL ANTIBODY (CC49) TO TUMOR ASSOCIATED GLYCOPROTEIN (TAG)-72 bulk offered by The Dow Chemical Company

    Find a price of SILASTIC 1808 ELASTOMER bulk offered by The Dow Chemical Company

    Find a price of SILASTIC 9711 MEDICAL GRADE ELASTOMER bulk offered by The Dow Chemical Company

    Find a price of SILICONE RUBBER DOW CORNING SILASTIC bulk offered by The Dow Chemical Company

    Find a price of INVESTIGATIONAL DRUG "MASTER FILE" FOR FUTURE REFS NOTICES T/B SUBMITT bulk offered by The Dow Chemical Company

    Find a price of VINYLITE BRAND COATED PAPER VDI 6645 WHITE 1435 bulk offered by The Dow Chemical Company

    Find a price of RHOZYME J-25 CONCENTRATE bulk offered by The Dow Chemical Company

    Find a price of BROMINATED SALICYLANILIDE bulk offered by The Dow Chemical Company

    Find a price of FACILITIES IN SHIZOUKA, JAPAN bulk offered by The Dow Chemical Company

    Find a price of UNION CARBIDE'S SENTRY SIMETHICONE USP & 30% EMUL bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL, BPA-1000 bulk offered by The Dow Chemical Company

    Find a price of 20% OXYGEN, 80% ARGON AS MANUF AT TORRENCIE, CA bulk offered by The Dow Chemical Company

    Find a price of MONOCLONAL ANTIBODY CC49 bulk offered by The Dow Chemical Company

    Find a price of SYNTHETIC SODIUM ALUMINOSILICATE ABSORBENTS (MOLECULAR SIEVES) bulk offered by The Dow Chemical Company

    Find a price of HYAMINE 1622 CRYSTALS (BENSETHONIUM CHLORIDE) bulk offered by The Dow Chemical Company

    Find a price of MURINE MONOCLONAL ANTIBODY (COL-1) TO CEA bulk offered by The Dow Chemical Company

    Find a price of PERSONNEL HANDLING NEW DRUG SUBSTANCES bulk offered by The Dow Chemical Company

    Find a price of BIO-RELEASE SILICONE RELEASE COATING SYSTEM, HEMLOCK, MI bulk offered by The Dow Chemical Company

    Find a price of PEI 600 POLYETHYLENIMINE bulk offered by The Dow Chemical Company

    Find a price of PROPYLENE GLYCOL--TRADE NAME SIRLENE (VET) bulk offered by The Dow Chemical Company

    Find a price of ETHYCELLULOSE DISPERSIONS bulk offered by The Dow Chemical Company

    Find a price of HYAMINE X (QUATERNARY AMMONIUM CHLORIDE COMPOUND) bulk offered by The Dow Chemical Company

    Find a price of ASPERKINASE PRODUCTION bulk offered by The Dow Chemical Company

    Find a price of ETHOXYLATED POLYETHYLENIMINE, MONTREK 600E bulk offered by The Dow Chemical Company

    Find a price of FACILITIES & CONTROLS (METHOXY FLURANE) bulk offered by The Dow Chemical Company

    Find a price of RHOZYME 41 CONCENTRATE bulk offered by The Dow Chemical Company

    Find a price of UCC MASTER MILKER SYSTEM FOR TC-99 EXTRACTION FROM MO-99 bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL, BPA-1050 bulk offered by The Dow Chemical Company

    Find a price of VERSENE CA. CALCIUM CHELATING AGENT bulk offered by The Dow Chemical Company

    Find a price of DISIDIUM DIHYDROGEN VERSENATE, A.R. bulk offered by The Dow Chemical Company

    Find a price of ZIRCONIA TEXTILES bulk offered by The Dow Chemical Company

    Find a price of POLYTHIOL RESIN bulk offered by The Dow Chemical Company

    Find a price of TERGITOL MONIONIC SURFACTANT 12-M-10 bulk offered by The Dow Chemical Company

    Find a price of POLYMER JR & LR RESINS bulk offered by The Dow Chemical Company

    Find a price of BIOCRYL BPA-5050PMN bulk offered by The Dow Chemical Company

    Find a price of HYDROXYETHYL METHACRYLATE 94% bulk offered by The Dow Chemical Company

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PITTSBURG, CAL. bulk offered by The Dow Chemical Company

    Find a price of TROLENE FM MEDICATED PREMIX bulk offered by The Dow Chemical Company

    Find a price of UNS-TETRAFLUOROETHANE bulk offered by The Dow Chemical Company

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MIDLAND, MICHIGAN. bulk offered by The Dow Chemical Company

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search